Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Afandin
Beijing, Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Afandin is a biotechnology company based in Beijing, China, that specializes in the discovery and development of novel therapeutics targeting the Afadin (AF6) protein. The company leverages its proprietary platform to identify small molecule inhibitors and modulators that address Afadin's role in cell adhesion, signaling, and tumor progression. Afandin's primary focus is on oncology, particularly in treating solid tumors where Afadin dysregulation is a key driver of metastasis and drug resistance. In addition to its internal pipeline, the company provides specialized contract research services (CRO) in the fields of molecular biology and drug screening.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Afandin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Afandin.